Colon AiQ
Colon AiQ Test – Early Colon Cancer Detection
Colon AiQ offers the opportunity for those who need to be screened, but postpone colonoscopy, to have a first thorough screening using molecular biology techniques to determine if there is a serious reason for an immediate colonoscopy. It also provides an intermediate screening option for individuals with confirmed colon syndromes or a family history of cancer, where frequent screening is required, as they are in high-risk groups for developing colon cancer.
Oncotype DX®
The only test in the world that predicts
patient's response to chemotherapy
in early breast cancer
HerediGENE®
HerediGENE® is a diagnostic multi-gene test for hereditary cancer, which analyses 52 genes, including BRCA1 and BRCA2, which are involved in the increased risk of breast, ovarian, prostate, colorectal and other hereditary cancers.
Com.pl.i.t DX®
Personalised treatment based on tumour biology
For patients with lung, colorectal and breast cancer
Prime DX
Precision Individualized Medicine
For an effective personalised treatment plan for cancer
Avantect®
A pioneering test for the early detection and early diagnosis of pancreatic cancer
Signatera®
Molecular detection of minimal residual disease in blood